Par Sterile Products recalls

Par Sterile Products has 4 recalls on record with the FDA and USDA, the earliest in 2017 and the latest reported on 3 Apr 2024. 2 are still ongoing. The most frequent reason is particulate matter.

Total recalls4since 2017

Last 12 months0reported

Class I125% of total

Ongoing2latest 3 Apr 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 1 25%Class II 3 75%Class III 0 0%

Why par sterile products is recalled

Product types

Injectable & IV Drugs4100%

Brands

Buprenorphine Hydrochloride250%
Vasostrict125%

By year

2024250%
2023125%
2017125%

Ongoing par sterile products recalls

2 active

Reported	Class	Recall	Company	Reason	Where
3 Apr 2024Drug	CLASS I	Treprostinil Injection, 20 mg/ (1 mg/mL) recalled	Par Sterile Products	Particulate Matter	Nationwide
24 Jan 2024Drug	CLASS II	Vasostrict (vasopressin in 5% Dextrose) Injection recalledVasostrict	Par Sterile Products	Potency & Assay	Nationwide

All par sterile products recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
3 Apr 2024Drug	CLASS I	Treprostinil Injection, 20 mg/ (1 mg/mL) recalled	Par Sterile Products	Particulate Matter	Nationwide
24 Jan 2024Drug	CLASS II	Vasostrict (vasopressin in 5% Dextrose) Injection recalledVasostrict	Par Sterile Products	Potency & Assay	Nationwide
15 Nov 2023Drug	CLASS II	Buprenorphine HCl, Injection, 3mg/mL recalled by PAR Sterile ProductsBuprenorphine Hydrochloride	PAR Sterile Products	Packaging Defects	Nationwide
17 May 2017Drug	CLASS II	Buprenorphine HCI Injection, 3 mg/mL Single Dose Vial recalledBuprenorphine Hydrochloride	PAR Sterile Products	Particulate Matter	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.